MOTHERISK ROUNDS: The Use of Antidepressants in Pregnancy: Focus on Maternal Risks

Keyphrases

• Antidepressants 100%
• Maternal Risk 100%
• During Pregnancy 25%
• Bleeding Risk 25%
• Fetal Risk 25%
• Preeclampsia 25%
• Selective Serotonin Reuptake Inhibitors 25%
• Untreated Depression 25%
• Maternal Morbidity 25%
• Serotonin-norepinephrine Reuptake Inhibitors 25%
• Pre-pregnancy 25%
• Risk-benefit Ratio 25%
• Hypertension Risk 25%
• Pregnancy Period 25%

Medicine and Dentistry

• Antidepressant 100%
• Bleeding 33%
• Fetus Risk 33%
• Pre-Eclampsia 33%
• Selective Serotonin Reuptake Inhibitor 33%
• Maternal Morbidity 33%
• Norepinephrine Reuptake Inhibitor 33%
• Risk-Benefit Ratio 33%
• Somatics 33%

Pharmacology, Toxicology and Pharmaceutical Science

• Antidepressant 100%
• Bleeding 33%
• Fetus Risk 33%
• Preeclampsia 33%
• Selective Serotonin Reuptake Inhibitor 33%
• Norepinephrine Reuptake Inhibitor 33%
• Maternal Morbidity 33%